The unique chemistry of benzoxaboroles: current and emerging applications in biotechnology and therapeutic treatments.

[1]  Yuting Zhang,et al.  Benzoboroxole-functionalized magnetic core/shell microspheres for highly specific enrichment of glycoproteins under physiological conditions. , 2014, Small.

[2]  Aurélien Lesnard,et al.  First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. , 2014, Journal of medicinal chemistry.

[3]  R. Wu,et al.  The Active Site Sulfenic Acid Ligand in Nitrile Hydratases Can Function as a Nucleophile , 2014, Journal of the American Chemical Society.

[4]  Baorui Liu,et al.  The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors. , 2014, Biomaterials.

[5]  J. Trujillo-Ferrara,et al.  Boron-containing acids: preliminary evaluation of acute toxicity and access to the brain determined by Raman scattering spectroscopy. , 2014, Neurotoxicology.

[6]  D. Westerberg,et al.  Onychomycosis: Current trends in diagnosis and treatment. , 2013, American family physician.

[7]  K. Jarnagin,et al.  Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[8]  J. Dubuisson,et al.  Phenylboronic-acid-modified nanoparticles: potential antiviral therapeutics. , 2013, ACS applied materials & interfaces.

[9]  K. Jarnagin,et al.  Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents. , 2013, Bioorganic & medicinal chemistry letters.

[10]  W. Maison,et al.  Synthesis of Adamantane‐Based Trimeric Benzoboroxoles , 2013 .

[11]  S. Benkovic,et al.  Capturing a sulfenic acid with arylboronic acids and benzoxaborole. , 2013, Journal of the American Chemical Society.

[12]  Yinan Lin,et al.  The synthesis of benzoxaboroles and their applications in medicinal chemistry , 2013, Science China Chemistry.

[13]  Michael A. Corsello,et al.  Synthesis and Biological Evaluation of Novel Benzoxaboroles as Potential Antimicrobial and Anticancer Agents , 2013 .

[14]  H. Taguchi,et al.  Biomolecular robotics for chemomechanically driven guest delivery fuelled by intracellular ATP. , 2013, Nature chemistry.

[15]  V. Ciaravino,et al.  An assessment of the genetic toxicology of novel boron‐containing therapeutic agents , 2013, Environmental and molecular mutagenesis.

[16]  M. Cyrański,et al.  Benzoxaborolate ligands in group 13 metal complexes , 2013 .

[17]  A. K. Yatsimirsky,et al.  Substituent effects and pH profiles for stability constants of arylboronic acid diol esters. , 2013, The Journal of organic chemistry.

[18]  M. Preobrazhenskaya,et al.  Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles. , 2013, Future medicinal chemistry.

[19]  P. Ramachandran.  Focusing on boron in medicinal chemistry. , 2013, Future medicinal chemistry.

[20]  Kate S. Carroll,et al.  Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery , 2013, Chemical reviews.

[21]  Ronald N. Jones,et al.  Potency and Spectrum of Activity of AN3365, a Novel Boron-Containing Protein Synthesis Inhibitor, Tested against Clinical Isolates of Enterobacteriaceae and Nonfermentative Gram-Negative Bacilli , 2013, Antimicrobial Agents and Chemotherapy.

[22]  K. Jarnagin,et al.  Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent. , 2013, Bioorganic & medicinal chemistry letters.

[23]  Y. Kotsuchibashi,et al.  Temperature, pH, and Glucose Responsive Gels via Simple Mixing of Boroxole- and Glyco-Based Polymers. , 2013, ACS macro letters.

[24]  E. Goldstein,et al.  Comparative In Vitro Activities of GSK2251052, a Novel Boron-Containing Leucyl-tRNA Synthetase Inhibitor, against 916 Anaerobic Organisms , 2013, Antimicrobial Agents and Chemotherapy.

[25]  P. Kennedy.  Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness) , 2013, The Lancet Neurology.

[26]  J. Nieman,et al.  Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria , 2013, Antimicrobial Agents and Chemotherapy.

[27]  E. Tomecka,et al.  Lewis acidity and sugar receptor activity of 3-amino-substituted benzoxaboroles and their ortho-aminomethylphenylboronic acid analogues , 2013 .

[28]  Tony T. Huang.  Deubiquitinases as a signaling target of oxidative stress , 2012, Cell reports.

[29]  S. Benkovic,et al.  Examination of the reactivity of benzoxaboroles and related compounds with a cis-diol. , 2012, The Journal of organic chemistry.

[30]  K. Jarnagin,et al.  Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery. , 2012, Journal of pharmaceutical and biomedical analysis.

[31]  John P A Ioannidis,et al.  Neglected tropical diseases: survey and geometry of randomised evidence , 2012, BMJ : British Medical Journal.

[32]  G. Yeo,et al.  Endoplasmic Reticulum Thiol Oxidase Deficiency Leads to Ascorbic Acid Depletion and Noncanonical Scurvy in Mice , 2012, Molecular cell.

[33]  K. Jarnagin,et al.  Boron‐based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center , 2012, FEBS letters.

[34]  Kate S. Carroll,et al.  Redox-Sensitive Sulfenic Acid Modification Regulates Surface Expression of the Cardiovascular Voltage-Gated Potassium Channel Kv1.5 , 2012, Circulation research.

[35]  J. Burrows,et al.  The global pipeline of new medicines for the control and elimination of malaria , 2012, Malaria Journal.

[36]  Agnieszka Adamczyk-Woźniak,et al.  Biological activity of selected boronic acids and their derivatives , 2012 .

[37]  Zhen Liu,et al.  Recent advances in monolithic column-based boronate-affinity chromatography , 2012 .

[38]  S. Martinis,et al.  Structural dynamics of the aminoacylation and proof-reading functional cycle of bacterial leucyl-tRNA synthetase , 2012, Nature Structural &Molecular Biology.

[39]  P. Baran,et al.  Scalable, divergent synthesis of meroterpenoids via "borono-sclareolide". , 2012, Journal of the American Chemical Society.

[40]  C. Furdui,et al.  A simple and effective strategy for labeling cysteine sulfenic acid in proteins by utilization of β-ketoesters as cleavable probes. , 2012, Chemical communications.

[41]  Yunchun Liu,et al.  A benzoboroxole-functionalized monolithic column for the selective enrichment and separation of cis-diol containing biomolecules. , 2012, Chemical communications.

[42]  M. Montenarh,et al.  Control of oxidative posttranslational cysteine modifications: from intricate chemistry to widespread biological and medical applications. , 2012, Chemical research in toxicology.

[43]  B. Nare,et al.  Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents. , 2012, Journal of medicinal chemistry.

[44]  Kyoung Taek Kim,et al.  Monosaccharide-responsive release of insulin from polymersomes of polyboroxole block copolymers at neutral pH. , 2012, Journal of the American Chemical Society.

[45]  R. Raines,et al.  Boronate-Mediated Biologic Delivery , 2012, Journal of the American Chemical Society.

[46]  F. Gamo,et al.  Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. , 2012, Bioorganic & medicinal chemistry letters.

[47]  S. Benkovic,et al.  Elucidation of the mechanism of the reaction between phenylboronic acid and a model diol, Alizarin Red S. , 2012, The Journal of organic chemistry.

[48]  Stephen J Benkovic,et al.  Ring Structure and Aromatic Substituent Effects on the pK a of the Benzoxaborole Pharmacophore. , 2012, ACS medicinal chemistry letters.

[49]  F. Scheller,et al.  Label‐free detection of enhanced saccharide binding at pH 7.4 to nanoparticulate benzoboroxole based receptor units , 2011, Journal of molecular recognition : JMR.

[50]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[51]  D. Hall.  Boronic acids : preparation and applications in organic synthesis, medicine and materials , 2011 .

[52]  J. Balzarini,et al.  Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry. , 2011, Molecular pharmaceutics.

[53]  J. Plattner,et al.  Synthesis of novel benzoxaborole-containing phenylalanine analogues , 2011 .

[54]  B. Nare,et al.  Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis. , 2011, Future medicinal chemistry.

[55]  Goedele Roos,et al.  Protein sulfenic acid formation: from cellular damage to redox regulation. , 2011, Free radical biology & medicine.

[56]  S. Benkovic,et al.  Boron-containing inhibitors of synthetases. , 2011, Chemical Society reviews.

[57]  Yunchun Liu,et al.  A Wulff-type boronate for boronate affinity capture of cis-diol compounds at medium acidic pH condition. , 2011, Chemical communications.

[58]  B. Nare,et al.  SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis , 2011, PLoS neglected tropical diseases.

[59]  F. Scheller,et al.  Molecular imprinting of fructose using a polymerizable benzoboroxole: Effective complexation at pH 7.4 , 2011 .

[60]  C. Page,et al.  Phosphodiesterase inhibitors in the treatment of inflammatory diseases. , 2011, Handbook of experimental pharmacology.

[61]  Yi Xia,et al.  Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[62]  Z. Ni,et al.  Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties. , 2011, Bioorganic & medicinal chemistry letters.

[63]  Yaxue Zhao,et al.  Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents. , 2011, Journal of medicinal chemistry.

[64]  Z. Ni,et al.  Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease. , 2010, Bioorganic & medicinal chemistry letters.

[65]  Gregory M. Peterson,et al.  Toenail onychomycosis: an important global disease burden , 2010, Journal of clinical pharmacy and therapeutics.

[66]  R. Zhuo,et al.  Enhanced gene transfection capability of polyethylenimine by incorporating boronic acid groups. , 2010, Chemical communications.

[67]  Z. Ni,et al.  Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 protease. , 2010, Bioorganic & medicinal chemistry letters.

[68]  K. Noguchi,et al.  Kinetic and structural studies on roles of the serine ligand and a strictly conserved tyrosine residue in nitrile hydratase , 2010, JBIC Journal of Biological Inorganic Chemistry.

[69]  D. Hall,et al.  Design, synthesis, and screening of a library of peptidyl bis(boroxoles) as oligosaccharide receptors in water: identification of a receptor for the tumor marker TF-antigen disaccharide. , 2010, Angewandte Chemie.

[70]  D. Katz,et al.  Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. , 2010, Molecular pharmaceutics.

[71]  Agnieszka Adamczyk-Woźniak,et al.  Benzoxaboroles – Old compounds with new applications , 2009 .

[72]  Kate S. Carroll,et al.  Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies , 2009, Proceedings of the National Academy of Sciences.

[73]  K. R. Maples,et al.  Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. , 2009, Bioorganic & medicinal chemistry letters.

[74]  M. Yohda,et al.  Catalytic Mechanism of Nitrile Hydratase Proposed by Time-resolved X-ray Crystallography Using a Novel Substrate, tert-Butylisonitrile* , 2008, Journal of Biological Chemistry.

[75]  D. Hall,et al.  Benzoboroxoles as efficient glycopyranoside-binding agents in physiological conditions: structure and selectivity of complex formation. , 2008, The Journal of organic chemistry.

[76]  C. Winterbourn,et al.  Reconciling the chemistry and biology of reactive oxygen species. , 2008, Nature chemical biology.

[77]  Vincent Hernandez,et al.  An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site , 2007, Science.

[78]  S. Baker,et al.  Recent progress on the topical therapy of onychomycosis , 2007, Expert opinion on investigational drugs.

[79]  S. Baker,et al.  Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis. , 2006, Journal of medicinal chemistry.

[80]  D. Hall,et al.  An improved class of sugar-binding boronic acids, soluble and capable of complexing glycosides in neutral water. , 2006, Journal of the American Chemical Society.

[81]  D. Barford.  The role of cysteine residues as redox-sensitive regulatory switches. , 2004, Current opinion in structural biology.

[82]  Michael P. Myers,et al.  Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate , 2003, Nature.

[83]  Andreas Link,et al.  Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase. , 2003, Molecular cell.

[84]  L. Piddock,et al.  The importance of efflux pumps in bacterial antibiotic resistance. , 2003, The Journal of antimicrobial chemotherapy.

[85]  N. Shear,et al.  A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis , 2000, Drug safety.

[86]  B. Elewski.  Onychomycosis. Treatment, quality of life, and economic issues. , 2000, American journal of clinical dermatology.

[87]  P. Kiprof,et al.  SYNTHESIS AND STRUCTURE OF BENZOBOROXOLES: NOVEL ORGANOBORON HETEROCYCLES , 1999 .

[88]  D. Patrick,et al.  The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. , 1999, Journal of the American Academy of Dermatology.

[89]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[90]  N. Miyaura,et al.  Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters , 1995 .

[91]  G. Wulff,et al.  Selective binding to polymers via covalent bonds. The construction of chiral cavities as specific receptor sites , 1982 .

[92]  H. Snyder,et al.  Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1 , 1958 .